Investment Test Drive

GDXS ProShares UltraShort Gold Miners

4 lower fee alternatives found

FeeX scanned the market for similar funds with lower fees and better past returns
Show results with
Fund GDXS ProShares UltraShort Gold Miners PILS Direxion Daily Pharmctcl&Medcl Br 2X ETF EMSA iPath® Short Enh MSCI Emerg Mkts ETN  
100% 92% 85%
Annual Fees
(0.95% Exp. Ratio)
(0.81% Exp. Ratio)
(0.80% Exp. Ratio)
Future Est. Balance in 30 yrs
Assuming -9.66% annual return
$356.00 $371.41 $372.53
Est. savings over 30 yrs +$15.41 +$16.53
As of 9/30/16
1 YR RETURN -88.01%
3 YR --
5 YR --
10 YR --
1 YR RETURN -13.83%
3 YR --
5 YR --
10 YR --
1 YR RETURN -30.07%
3 YR -4.94%
5 YR -10.16%
10 YR --
The investment seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the NYSE Arca Gold Miners Index. The fund invests in derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times the inverse (-2x) of the daily return of the index. The index is a modified market-capitalization weighted index primarily comprised of publicly traded companies involved in the mining of gold and silver. The fund is non-diversified.
The investment seeks daily investment results of 200% of the inverse of the performance of the Dynamic Pharmaceutical Intellidex Index. The fund, under normal circumstances, creates short positions by investing at least 80% of its assets in: swap agreements; futures contracts; options; reverse repurchase agreements; exchange-traded funds ("ETFs"); and other financial instruments that, in combination, provide inverse leveraged and unleveraged exposure to the Dynamic Pharmaceutical Intellidex Index. The index consists of common shares of U.S. pharmaceutical companies. It is non-diversified.
The iPath® Short Enhanced MSCI Emerging Markets Index ETN is designed to provide investors with leveraged return on the inverse performance of the MSCI Emerging Markets Net Total Return Index. The MSCI Emerging Markets Net Total Return Index is a free float-adjusted market capitalization Index that is designed to offer a representation of equity market performance of emerging markets.

Join FeeX to view all alternatives, get more data and filtering options, and be able to automatically scan all your investments for lower fee replacements.

It's free!

The fees, balance and savings information above are estimated numbers, based on the data FeeX had at the day of publication, but may not be accurate due to incomplete or erroneous data.

The best choice is based on a combined analysis of lowest fees and highest similarity to the original fund.


FeeX's similarity algorithm analyzes over 15 investment characteristics like investment category, asset allocation, strategy, geographical allocation and more. FeeX gives each its own weight and calculates the similarity of any two investments based on a scale of 0 to 100%. Funds with a similarity ranking of 85% and higher are considered "similar".

Yes, funds and ETFs charge fees

Deep within every fund you own lies a hidden fee called expense ratio. It takes away a set % of your savings each and every year. It can often be easily reduced by switching to similar investments with lower expense ratios.


Your Feedback has been sent successfully!